ABUS logo
ABUS

Arbutus Biopharma Corp

Biotechnology

Arbutus Biopharma Corp (ABUS) Earnings

Last reported
April 30, 2026
EPS estimate
-$0.03
EPS actual
Revenue est.
$765.0K
Revenue actual